Sex-related differences in survival based on [18F]FDG PET/CT metabolic tumor volume after liver transplantation for colorectal liver metastases
Transplant International · 16.06.2026 · 39
DOI: 10.3389/ti.2026.16406 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant International, online erschienen am 16.06.2026. Verfasst von Nadide Mutlukoca Stern und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Vestre Viken Hospital Trust, Drammen, Norway. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Liver Neoplasms, Colorectal Neoplasms, Liver Transplantation. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
[ 18 F]FDG PET/CT-derived metabolic tumor volume (MTV) is a strong prognostic biomarker in patients undergoing liver transplantation (LT) for non-resectable colorectal liver metastases (nCRLM). This study aimed to evaluate whether MTV-based survival outcomes after LT for nCRLM differ between males and females. Patients who underwent LT for nCRLM between 2006 and 2022 were included (n = 45). Baseline characteristics were compared using the Mann–Whitney U test and Fisher’s exact test. Overall survival (OS), disease-free survival (DFS), and survival after relapse (SAR) were estimated using Kaplan–Meier analysis with the log-rank test. Cox regression analyses including sex, dichotomized MTV, and an interaction term between sex and MTV were performed. Female patients had significantly shorter OS compared with male patients (median 58 vs. 92 months, p = 0.047). Low MTV was associated with significantly longer OS, DFS and SAR in both sexes. Among patients with high MTV, females had significantly shorter OS than males (median 25 vs. 59 months, p < 0.001). Females had more non-pulmonary recurrences than males ( p = 0.006) and shorter median SAR than males (17 vs. 46 months, p < 0.001) with high MTV. A significant interaction between sex and MTV was observed, indicating a particularly adverse prognostic impact of high MTV in female patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Vestre Viken Hospital Trust, Drammen, Norway.
- Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
- Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
- Nuclear Medicine and Radiation Biology Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
Zitieren
APA
Mutlukoca Stern, N., Dueland, S., Line, P. D., Syversveen, T., & Grut, H. (2026). Sex-related differences in survival based on [18F]FDG PET/CT metabolic tumor volume after liver transplantation for colorectal liver metastases. Transplant International, 39. https://doi.org/10.3389/ti.2026.16406
Vancouver
Mutlukoca Stern N, Dueland S, Line PD, Syversveen T, Grut H. Sex-related differences in survival based on [18F]FDG PET/CT metabolic tumor volume after liver transplantation for colorectal liver metastases. Transplant International. 2026;39. doi:10.3389/ti.2026.16406
BibTeX
@article{MutlukocaStern2026,
author = {Mutlukoca Stern, Nadide and Dueland, Svein and Line, Pål-Dag and Syversveen, Trygve and Grut, Harald},
title = {Sex-related differences in survival based on [18F]FDG PET/CT metabolic tumor volume after liver transplantation for colorectal liver metastases},
journal = {Transplant International},
year = {2026},
volume = {39},
doi = {10.3389/ti.2026.16406}
}
EUVIMED